--(BUSINESS WIRE)--Paragonix Technologies designs, produces, and sells organ preservation and transport devices that safeguard organs during the journey between donor and recipient patients. Our award-winning devices mitigate risk in an otherwise high stakes environment. The Paragonix SherpaPak systems incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix SherpaPak™ CTS is the only commercially available FDA cleared and CE marked transport device for heart preservation. Paragonix is also developing transport devices for the lung, pancreas, kidney and liver designed to improve donor organ quality and extend donor organ transport time.
Company: |
Paragonix Technologies |
|
|
|
|
Headquarters Address: |
222 Third Street |
|
|
2242 |
|
|
Cambridge, MA 02142 |
|
|
|
|
Main Telephone: |
(781) 428-4153 |
|
|
|
|
Website: |
||
|
|
|
Type of Organization: |
Private |
|
|
|
|
Industry: |
Medical Devices |
|
|
|
|
Key Executives: |
CEO: William Edelman |
|
|
|
|
Public Relations |
|
|
Contact: |
Michael Tajima |
|
Phone: |
(781) 428-4153 |
|
Email: |
